Therapeutic Goods (Poisons Standard) (Benzylpenicillin - Seqirus) Exemption 2022
Published
Related content
- Therapeutic Goods (Poisons Standard) (COVID-19 Treatment - Gilead) (Remdesivir) Labelling Exemption 2021This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Famtozinameran) Labelling Exemption 2023This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Moderna) Labelling Exemption 2021This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.